Praser Therapeutics Secures $50 Billion in Latest Pre-Seed Funding Round

Praser Therapeutics secured $50 billion in its latest Pre-Seed, adding another data point to the Healthcare & Life Sciences funding market.

Praser Therapeutics Raises $50 billion in Funding

Praser Therapeutics raises ₩50 billion in pre-IPO funding. Claim This Offer Sign In Terms of Service Privacy Policy Do Not Sell or Share My Personal Information We've updated our terms By accepting, you agree to our updated Terms of Service, including the arbitration provision and class action waiver.

Investors Behind the Funding

The round was backed by No Limit Holdings. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Praser Therapeutics operates in Healthcare & Life Sciences. Praser Therapeutics's financing adds to recent private-market activity.

Strategic Use of Funds

The company is expected to use the new capital to expand its platform, support customers, and continue scaling.

Looking Ahead

Techdollar is well positioned at the cross-section of frontier tech RWAs and DeFi,

Source reference: original announcement/article.